• 대한두개안면성형외과학회지
• /
• 제24권2호
• /
• pp.52-58
• /
• 2023

Background: Complex orbital fractures are impure orbital fractures because they involve the orbital walls and mid-facial bones. The author reported an orbital wall restoration technique in which the primary orbital wall fragments were restored to their prior position in complex orbital fractures in 2020. As a follow-up to a previous preliminary study, this study retrospectively reviewed the surgical results of complex orbital wall fractures over a 4-year period and compared the surgical outcomes by dividing them into groups with and without balloon restoration. Methods: Data of 939 patients with facial bone fractures between August 2018 and August 2022 were reviewed. Of these, 154 had complex orbital fractures. Among them, 44 and 110 underwent reduction with and without the balloon technique respectively. Pre- and postoperative Naugle exophthalmometer (Good-Lite Co.) scales were evaluated. The orbital volume and orbital volume ratio were calculated from preoperative and 6 months postoperative computed tomography images. Results: Among 154 patients with complex orbital fractures, 44 patients underwent restoration with the balloon technique, and 110 patients underwent restoration without it. The Naugle scale did not differ significantly between the two groups, but the orbital volume ratio significantly decreased by 3.32% and 2.39% in groups with and without the balloon technique and the difference in OVR was significantly greater in patients in the balloon restoration group compared with the control group. Postoperative balloon rupture occurred in six out of 44 cases (13.64%). None of the six patients with balloon rupture showed significant enophthalmos at 6 months of follow-up. Conclusion: The balloon rupture rate was 13.64% (6/44 cases) with marginal screw fixation, blunt screws, and extra protection with a resorbable foam dressing. Furthermore, we restored the orbital wall with primary orbital fragments using balloon support in complex orbital wall fractures.

• 자원리싸이클링
• /
• 제14권2호
• /
• pp.19-27
• /
• 2005

알루미늄 폐드로스를 이용한 다공성 경량세라믹의 제조조건을 제시함으로서 폐드로스의 요업용 원료로서의 재활용가능성을 살펴보았다. 알루미늄 폐드로스의 전처리 과정으로 4~7번의 수세와 900$^{\circ}%의 배소를 수행하여 수세와 배소 특성을 살펴보았다. 배소 후 드로스는 XRD분석에 의해 스피넬상이 형성되었다. 배소된 폐드로스는 슬러리 상태로 분쇄되었다. 분쇄시 슬러리의 분산성을 확보하여 고농도의 슬러리를 제조하기 위해 분산조제 첨가량에 따른 분산특성을 살펴보았다. 다공체는 슬러리 발포법을 사용하여 제조되었다. 발포조제로 계면활성제가 첨가되었으며 상온에서 자기체적의 2-3배로 발포된 후 성형-건조되었다. 3배 발포시켜 제조된 다공체는 기공율이 약 84%, bulk 밀도는 약 0.59 g/cm$^3$로 측정되었고, 50~500 ${\mu}m$ 크기범위의 기공들이 형성되었다. 화상해석결과 다공체 표면의 평균기공크기는 약 200 ${\mu}m$ 였다. 알루미늄 폐드로스 성형체는 1150$^{\circ}C-1250$^{\circ}C에서 소결되었으며, SEM관찰결과 1200$^{\circ}C에서 소결특성이 양호한 것으로 나타났다.

• 콘크리트학회논문집
• /
• 제23권2호
• /
• pp.151-158
• /
• 2011

선발포 방식을 통해 제조되는 기포 콘크리트에서 기포는 밀도, 강도, 공극 등의 물리적 특성에 영향을 끼치는 주요인이다. 기포 콘크리트에 대한 연구가 꾸준하게 진행되었지만, 기포 자체의 특성에 관한 연구는 화학적인 분야를 제외하고는 거의 없는 실정이다. 그러므로 용도에 적합한 기포 콘크리트를 제조하기 위해서는 기포의 성상에 대한 연구가 필수적으로 선행되어야 한다. 기포 콘크리트의 제조에서 기포를 유효하게 이용하기 위해서는 기포의 특성을 평가해야만 한다. 이 연구에서는 기포의 특성을 알아보기 위해 기포제 종류 및 농도 변화에 따른 기포의 특성에 관한 검토를 수행하였다. 기포의 특성을 알아보기 위해 사용한 기포제는 계면활성제계, 수지비누계, 단백질계 기포제를 사용하였고 기포제의 농도는 기포제 종류에 따라 0.05~13% 범위로 설정하였다. 측정 항목은 발포율, 기포 용적, 수용액 용적, 기포 크기 및 분포를 측정하였다. 분석 결과, 기포제 종류와는 상관없이 기포제 농도가 높을수록 발포율은 증가하는 것으로 나타났고, 기포제 농도는 기포, 수용액 용적 변화, 기포 크기 분포에도 영향을 끼치는 것으로 나타났다. 기포의 안정성 측면에서 단백질계가 계면활성제, 수지비누계 보다 높은 안정성을 나타냈다. 기포의 형상에서는 계면활성제계, 수지 비누계는 다각형의 기포를, 단백질계는 구형의 기포를 형성하였다.

• Clinical and Experimental Otorhinolaryngology
• /
• 제11권4호
• /
• pp.281-287
• /
• 2018

Objectives. Regenerative treatment using stem cells may serve as treatment option for empty nose syndrome (ENS), which is caused by the lack of turbinate tissue and deranged nervous system in the nasal cavity. We aimed to assess the efficacy and safety of the autologous stromal vascular fraction (SVF) in the treatment of ENS. Methods. In this prospective observational clinical study, we enrolled 10 ENS patients who volunteered to undergo treatment of ENS through the injection of autologous SVF. Data, including demographic data, pre- and postoperative Sino-Nasal Outcome Test-25 (SNOT-25) scores, overall patient satisfaction, and postoperative complications, were prospectively collected. Nasal secretion was assessed using the polyurethane foam absorption method, and the levels of biological markers were analyzed in both ENS group and control group using enzyme-linked immunosorbent assay. The SVF extracted from abdominal fat was diluted and injected into both inferior turbinates. Results. Among the 10 initial patients, one was excluded from the study. Subjective satisfaction was rated as "much improved" in two and "no change" in seven. Among the improved patients, the mean preinjection SNOT-25 score was 55.0 and the score at 6 months after injection was 19.5. However, the average SNOT-25 score of nine participants at 6 months after injection (mean${\pm}$standard deviation, $62.4{\pm}35.8$) did not differ significantly from the baseline SNOT-25 score ($70.1{\pm}24.7$, P>0.05, respectively). Among the various inflammatory markers assessed, the levels of interleukin $(IL)-1{\beta}$, IL-8, and calcitonin gene-related peptide were significantly higher in ENS patients. Compared with preinjection secretion level, the nasal secretions from SVF-treated patients showed decreased expressions of $IL-1{\beta}$ and IL-8 after injection. Conclusion. Although SVF treatment appears to decrease the inflammatory cytokine levels in the nasal mucosa, a single SVF injection was not effective in terms of symptom improvement and patient satisfaction. Further trials are needed to identify a more practical and useful regenerative treatment modality for patients with ENS.